Gazyva 50242-0070
Generic: Obinutuzumab
Product NDC
50242-0070- Manufacturer
- Genentech, Inc.
- Dosage Form
- Injection, Solution, Concentrate
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- November 1, 2013
- Listing Expires
- December 31, 2026
- Application
- BLA125486
Need to source Gazyva? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Obinutuzumab | 1000 mg/40mL |
Drug Class
CD20-directed Cytolytic Antibody [EPC]CD20-directed Antibody Interactions [MoA]CD20-directed Cytolytic Antibody [EPC]
Packaging Options(2)
1 VIAL, SINGLE-USE in 1 CARTON (50242-070-01) / 40 mL in 1 VIAL, SINGLE-USE
1 VIAL, SINGLE-USE in 1 CARTON (50242-070-86) / 40 mL in 1 VIAL, SINGLE-USE